Malaria

College of Health Sciences
Dep. of Medical Laboratories
Parasitology Theory
3rd stage
Lecture 7
Dr.: Shameeran S. Ismael
BVM & S, M.Sc Medical Microbiology(Parasitology),
PhD Molecular Parasitology
Dr. Shameeran S., Medical Parasitology,
Health Sciences,2021

Plasmodium spp.
Malaria
Dr. Shameeran S., Medical Parasitology, Health Sciences,2021

Malaria
• Malaria is derived from Italian word
• Mal Bad
• Aria Air
Malaria is caused by members of Plasmodium
parasite :P. falciparum, P. vivax, P. ovale
and P. malariae and transmitted by
infected female anopheles mosquitoes

Plasmodium spp:
Kingdome: Protista
Phylum: Protozoa
Sub-phylum: Sporozoa
Class: Haemosporidia
Family: Plasmodidae
Genus: Plasmodium
Species: P. falciparum (Malignant tertian malaria)
P. vivax (Benign tertian malaria)
P. ovale (Ovale malaria)
P. malariae (Quartan malaria)

Human species including: P. falciparum, P. vivax, P. Ovale
and P. malariae
Intermediate host: human
Vector or final host: Mosquitoes (Female Anopheles)
Site of infection: Intracellular Protozoa (blood)
Infective stage: Sporozoites for intermediate host &
Gametocyte for Mosquitoes
Infection: When mosquitoes bite the human during blood
meals
Disease: Malaria

Morphology
1. Ring stage:
• Infected RBC first stage
a) Dot/rod shaped nucleus (red)
b) Peripheral rim of cytoplasm (blue)
c) Central clear vacuole like area (not stained)
Different species have different rings

2. Trophozoite:
It is irregular in shape (like ameboid like with
pseudopodia) within cytoplasm there are a brown
pigment granules (malarial pigment---haemozoin)

3. Schizont stage:
Trophozoites are multiply by binary fission Multiple
fission of Nucleus/Cytoplasm fragments (schizont)
Forming merozoites

4. Gametocytes:
• Male and female gametes
Male Gamete Female gamete

Life Cycle
Hosts:
• Definitive Host : Female anopheles (sexual cycle,
sporogony)
• Intermediate Host : Man (asexual cycle:
exoerythrocytic and endoerythrocytic or erythrocytic)
Vector:
• Female Anopheles

Besides infection by the bite of infected female
mosquito the infection may also be transmitted by:
• Transfusion of blood from a patient of malaria
• Transmission of infection to foetus in utero through
some placental defect (Congenital Malaria)
• By the use of contaminated syringes particularly in
drug addicts.

• Sexual cycle initiated in Humans Gametocytes
(gametogony in RBCs) mosquitoes take it during
biting and blood meal fusion of M/F gametes
zygote ookinete oocyst many
sporozoites (sporogony)
• Sexual cycle Sporogony (sporozoites)
• Asexual cycle Schizogony (schizonts)

In mosquitoe
Gametocytes(♀♂) gametes (♀♂)
(blood) (stomach of insect)
union of
zygote
rupture/release rounds up into
sporozoites oocyst motile ookinete
(Salivary glands) (inside the body cavity)

In intermediate host:
1. Exoerythrocytic stage
During biting and blood meal, inject the sporozoites into
the blood exoerythrocytic schizonts
(mosquito blood) (hepatic cell)
rupture/release
exoerythrocytic (merozoite)
( blood)

2. Erythrocytic stage
Ring stage later trophozoite
merozoite immature schizont
Mature schizont
*The process from trphozoite to merozoite is called
schizogony. Dr. Shameeran S., Medical Parasitology, Health Sciences,2021

3. Gametgenesis
----After completing a few schizogonic cycles, some
merozoites develop into sexual cells, the male and
female gametocytes. They continue their development in
the mosquito.

Malaria

P. falciparum is the most deadly one; because these
parasites promote physiologic changes of the red cell,
which causes agglutination and lysis. Schizogony takes
place in the capillaries and blood sinuses of the brain,
visceral organs, and placenta, with infected cells tending
to adhere to one another and to the surrounding vessel
walls. Vessels become blocked, causing local infarction
and damage to the regional tissue.
Pathogenesis

Causing cerebral malaria:
• This is the most commonest cause of coma and death
in P.falciparum malaria, particularly in children and
non immune adults.
• Many parasitized cells can be found in the capillaries
of the brain and in late stage, hemorrhaging from small
blood vessels can occur

Causing Blackwater Fever
• It is a rare but acute condition in which there is a
rapid and massive intravascular haemolysis of both
parasitized and non parasitized red blood cells
• It result in haemoglobinanemia, haemoglobinuria
(The urine appears dark red to brown-black).
• It can occur in non-immune adults with sever
P.falciparum malaria

Merozoites of P. malariae can invade only older cells;
those of P. vivax and P. ovale infect primarily
reticulocytes (immature RBCs) and the P. falciparum -
RBCs of every age.
A characteristic brown malaria pigment derived from
hemoglobin, called hematin is released from ruptured
RBCs and produces discoloration of the spleen. Liver,
lymph nodes and bone marrow.

 P. vivax is the most widely disseminated and most
prevalent parasite causing malaria. There is repeated
exoerythrocytic development in the liver; therefore, P.
vivax can cause a relapse (hypnozoites), with
erythrocytic cycles starting again years after the initial
infection sequence. This is thought to result from
sequestered hypnozoites in the liver. P. ovale can also
cause relapses, but infections with this parasite are
usually less severe and often resolve themselves
within 6 to 10 paroxysms

Some characteristics of infection with four
species of human Plasmodia
P.v. P.o. P.m. P.f.
Pre-
erythroctic
stage (days)
6-8 9 14-16 5.5-7
Pre-patent
period (days)
11-13 10-14 15-16 9-10
Incubation
period (days)
15 (12-17)
or up to 6-
12 months
17 (16-18)
or longer
28 (18-40)
or longer
12 (9-14)
Erythrocytic
cycle (hours)
48 (about) 50 72 48

• Complications of P.
falciparum malaria
– Cerebral malaria ( coma )
– Convulsions
– Hyperpyrexia
– Severe anemia
– Metabolic (Lactic) Acidosis
– jaundice
– renal failure
– Pulmonary odema & ARDS
– hypoglycemia
– Hypotention & shock
– Bleeding & clotting
disorder
– haemoglobinuria
– hyperparasitemia
– Associated infection
• Complications of P.
vivax / P. malariae
– Rupture of spleen
– Hepatic dysfunction
– Thrombocytopenia
– Severe anemia
– malarial nephropathy

Predisposing factors for complications
1. Extremes of age.
2. Pregnancy, especially in primigravidae and in 2nd
half of pregnancy.
3. Immunosuppressed - patients on steroids, anti- cancer
drugs, immunosuppressant drugs.
4. Immunocompromised patients with advanced
tuberculosis and cancers.
5. Splenectomy.
6. Lack of previous exposure to malaria (non-immune)
7. Pre-existing organ failure.
8. Traveling or living in a region where malaria is present.

Clinical signs
In case of P. falciparum:
• Tropics, 50% of malaria in the world
• Falciparum malaria, malignant tertian malaria
• The most dangerous type.
Clinical signs including:
• Malaise, headache, vomiting.
• Fever.
• Cough, diarrhea.
• Jaundice.
• Tender hepatosplenomegaly.
• Anemia develops rapidly.

Why P. falciparum Infections are
Dangerous
• Can produce fatal complications:
1.Cerebral malaria
2.Malarial hyperpyrexia
3.Gastrointestinal disorders.
4. Shock
5 Black water fever can lead to death

In case of P.vivax and P.oval:
• Fever: classically every 48 h.
• Rigors.
• Gradual hepatosplenomegaly.
• Anemia develops slowly.
• Relapse is common.

In case of P.malariae:
o Fever: every third day.
o Mild symptoms.
o Parasitaemia may persist for many years.
o Causes glomerulonephritis and nephrotic
syndrome in children.

Diagnosis
1.Malaria should be suspected clinically by make of :
• Thick and thin blood films:
• Thin films: essential to confirm the diagnosis and to
identify the species of the parasite.
2.Immunochromatographicor rapid diagnostic test: is
based on the detection of antigens derived from malaria
patients in lysed blood, using

3. Molecular Diagnosis:
Parasite nucleic acids are detected using
polymerase chain reaction (PCR). This technique is
more accurate than microscopy.

Treatment:
Treatment of P. vivax malaria:
1. Confirmed Cases:
Chloroquine in full therapeutic dose of 25
mg/kg divided over three days.
2. To prevent relapse (Hypnozoites ):
Primaquine 0.25 mg/kg bw daily for 14 days

Treatment of P. falciparum malaria:
• Artemisinin Combination Therapy (ACT)
ACT + with a long acting antimalarial
(amodiaquine, lumefantrine, mefloquine or
sulfadoxine-pyrimethamine).
• On day 2 , single dose of primaquine (0.75
mg/kg body weight).

Malaria Vaccines:
1 Anti-sporozoite vaccines
2 Anti-asexual blood stage vaccines
3 Transmission-blocking vaccines
Vaccines are being developed and tried but none is
available yet for routine use .

Environmental and
Behavioral
Modification
Genetic
modification
of vectors
Future Interventions
Vaccines
(preerythrocytic,
blood stage,
transmission-
blocking)
Protection
(insecticide-
impregnated
materials)
Drugs
(treatment,
prevention)
Insecticides
(house
spraying,
larvicides)
Control of Malaria

Thanks,,

Malaria

More Related Content

What's hot

Similar to Malaria

More from Dr. Shameeran Bamarni

Recently uploaded

Malaria